Adicet Bio Inc ACET:NASDAQ

Last Price$9.80NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$8.00 (10)
Ask (Size)$9.80 (1)
Day Low / HighN/A - N/A
Volume273.6 K
 

Read more news Recent News

Adicet Bio Promotes Blake Aftab to Chief Scientific Officer
4:21PM ET 10/12/2021 MT Newswires

Adicet Bio (ACET) said late Tuesday it promoted Blake Aftab to chief scientific officer. Aftab has served as vice president and head of research at the...

Adicet Bio Teams Up With Twist Bioscience to Boost Discovery of Cancer Therapies
10:05AM ET 9/13/2021 MT Newswires

Adicet Bio (ACET) and Twist Bioscience (TWST) have formed a collaboration to develop gamma delta T cell cancer-fighting therapies against five key targets,...

Insider Trends: Insider Prolongs 90-Day Selling Trend at Adicet Bio
4:27PM ET 6/21/2021 MT Newswires

Chen Schor, Director and President & CEO, sold 16,466 shares in Adicet Bio (ACET) for $173,443 on Jun 16, 2021. Subsequent to the Form 4 filing with the...

Insider Trends: 90-Day Insider Selling Trend Continued at Adicet Bio
7:14PM ET 6/07/2021 MT Newswires

Chen Schor, Director and President & CEO, sold 16,466 shares in Adicet Bio (ACET) on Jun 03, 2021, for $198,499. Schor, after the transactions described...

View all Commentary and Analysis

Adicet Bio (ACET) Investor Presentation - Slideshow
10:23AM ET 8/13/2021 Seeking Alpha

Week 17 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An Edge
7:08AM ET 4/25/2021 Seeking Alpha

LAVA Therapeutics Seeks $101 Million U.S. IPO
1:30PM ET 3/22/2021 Seeking Alpha

Adicet Bio (ACET) Investor Presentation - Slideshow
4:27AM ET 2/28/2021 Seeking Alpha

Company Profile

Business DescriptionAdicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA. View company web site for more details
Address500 Boylston Street
Boston, Massachusetts 02116
Phone+1.857.315.5528
Number of Employees21
Recent SEC Filing11/18/20214
President, CEO, Secretary & DirectorChen Schor
Chief Financial OfficerBrian Nicholas Harvey
Chief Medical Officer & Senior Vice PresidentFrancesco Galimi
Chief Technology OfficerDonald Healey

Company Highlights

Price Open$10.45
Previous Close$10.35
52 Week Range$6.25 - 17.80
Market Capitalization$313.2 M
Shares Outstanding32.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/10/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.05
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit Margin-570.14%
Return on Equity-27.86%

Analyst Ratings as of 05/17/2021

Buy
7
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset